Chronic Pain Clinical Trials

A listing of Chronic Pain medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35209

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Foley Alabama

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

UPDATED

Mobile Alabama 36608

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Mobile Alabama

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

Montgomery Alabama

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

Arizona

UPDATED

Mesa Arizona 85215

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Phoenix Arizona 85023

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Phoenix Arizona 85027

A clinical trial to evaluate treatments using Evoke Spinal Cord Stimulator (SCS) System for patients with Chronic Pain, Back Pain or Pain

Phoenix Arizona

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

Phoenix Arizona

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

View More ▼

Scottsdale Arizona 85258

A clinical trial to evaluate treatments using Evoke Spinal Cord Stimulator (SCS) System for patients with Chronic Pain, Back Pain or Pain

UPDATED

Tempe Arizona 85283

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Tucson Arizona 85712

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Tucson Arizona 85704

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Tucson Arizona 85712

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Tucson Arizona

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

Arkansas

Hot Springs Arkansas

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

California

Northern California Research
Sacramento California 95825

Complex Regional Pain Syndrome type 1 and 2

View More ▼

UPDATED

Anaheim California 92805

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Bellflower California 90706

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Beverly Hills California 90212

A clinical research study of Freedom SCS System - High Frequency and Freedom SCS System - Low Frequency for the treatment of Back Pain

UPDATED

Beverly Hills California 90211

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Canoga Park California 91303

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Carlsbad California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

UPDATED

Cerritos California 90703

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Covina California 91723

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

El Cajon California 92020

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Escondido California 92029

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Escondido California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

UPDATED

Huntington Beach California 92647

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

Huntington Beach California 92646

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Irvine California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

La Jolla California

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

UPDATED

La Mesa California 91942

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

UPDATED

La Mesa California 91941

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Laguna Woods California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

UPDATED

Lakewood California 90805

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Los Angeles California 90033

A clinical research study of Freedom SCS System - High Frequency and Freedom SCS System - Low Frequency for the treatment of Back Pain

UPDATED

Los Angeles California 90010

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Los Angeles California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

Los Angeles California

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

Los Gatos California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

Montclair California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

UPDATED

Napa California 94558

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Napa California

Patients are needed to participate in a clinical research study evaluating AXS-02 (oral zoledronate) and Placebo for the treatment of Chronic Regional Pain Syndrome - Type 1 or Reflex Sympathetic Dystrophy (crps-1)

UPDATED

North Hollywood California 91606

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee

Oceanside California

A Phase 4 clinical study for patients with Opioid-Related Disorders, Opiate Addiction, Narcotic Abuse or Drug Abuse

UPDATED

Orange California 92868

A clinical research study of NSAID, Tanezumab 2.5 mg and Tanezumab 5 mg for the treatment of Chronic Pain, Osteoarthritis of the Hip or Knee